MXPA05010064A - Analogos de tamandarin y fragmentos de los mismos y metodos para hacerlos y usarlos. - Google Patents

Analogos de tamandarin y fragmentos de los mismos y metodos para hacerlos y usarlos.

Info

Publication number
MXPA05010064A
MXPA05010064A MXPA05010064A MXPA05010064A MXPA05010064A MX PA05010064 A MXPA05010064 A MX PA05010064A MX PA05010064 A MXPA05010064 A MX PA05010064A MX PA05010064 A MXPA05010064 A MX PA05010064A MX PA05010064 A MXPA05010064 A MX PA05010064A
Authority
MX
Mexico
Prior art keywords
compound
compound according
further characterized
methyl
mmol
Prior art date
Application number
MXPA05010064A
Other languages
English (en)
Spanish (es)
Inventor
Madeleine M Joullie
Original Assignee
Madeleine M Joullie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Madeleine M Joullie filed Critical Madeleine M Joullie
Publication of MXPA05010064A publication Critical patent/MXPA05010064A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K11/00—Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0808—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/02—Linear peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA05010064A 2003-03-21 2004-03-19 Analogos de tamandarin y fragmentos de los mismos y metodos para hacerlos y usarlos. MXPA05010064A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45696703P 2003-03-21 2003-03-21
PCT/US2004/008275 WO2004084812A2 (en) 2003-03-21 2004-03-19 Tamandarin analogs and fragments thereof and methods of making and using

Publications (1)

Publication Number Publication Date
MXPA05010064A true MXPA05010064A (es) 2006-05-17

Family

ID=33098178

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05010064A MXPA05010064A (es) 2003-03-21 2004-03-19 Analogos de tamandarin y fragmentos de los mismos y metodos para hacerlos y usarlos.

Country Status (8)

Country Link
US (1) US8030279B2 (https=)
EP (1) EP1613338A4 (https=)
JP (1) JP2006523214A (https=)
CN (1) CN1819837A (https=)
AU (1) AU2004224418A1 (https=)
CA (1) CA2519234A1 (https=)
MX (1) MXPA05010064A (https=)
WO (1) WO2004084812A2 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302498B6 (cs) * 1999-11-15 2011-06-15 Pharma Mar, S. A. Farmaceutický prípravek obsahující aplidin pro lécení rakovinových onemocnení
CA2405779A1 (en) * 2000-04-07 2001-10-18 The Trustees Of The University Of Pennsylvania Tamandarin and didemnin analogs and methods of making and using them
US6509315B1 (en) 2000-04-07 2003-01-21 The Trustees Of The University Of Pennsylvania Didemnin analogs and fragments and methods of making and using them
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
EP2261323A1 (en) 2005-05-31 2010-12-15 The Iams Company Feline probiotic lactobacilli
JP4935675B2 (ja) 2005-08-25 2012-05-23 宇部興産株式会社 光学活性（Ｓ又はＲ）−α−アミノ酸及び光学活性（Ｒ又はＳ）−α−アミノ酸エステルの製造方法
WO2007101235A2 (en) 2006-02-28 2007-09-07 Pharma Mar, S.A. Improved antitumoral treatments
RU2436581C2 (ru) 2007-02-01 2011-12-20 Дзе Иамс Компани Способ уменьшения воспаления и снижения стресса у млекопитающего
JP5396016B2 (ja) * 2007-03-26 2014-01-22 学校法人青山学院 化合物又はその薬理上許容される塩若しくはエステル誘導体及び制癌剤
AU2008313627A1 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
WO2011020913A2 (en) 2009-08-21 2011-02-24 Pharma Mar, S.A. Cyclodepsipeptide antiviral compounds
CN104003908B (zh) * 2014-01-17 2016-08-17 宁波北仑大港科技创新服务中心 一种保护羟基的丝氨酸的制备方法
KR102491180B1 (ko) 2017-04-27 2023-01-20 파르마 마르 에스.에이. 항종양 화합물
CN115461067A (zh) 2020-03-02 2022-12-09 法马马有限公司 用于炎症的化合物
US20230158104A1 (en) 2020-03-02 2023-05-25 Pharma Mar, S.A. Compounds for use in autoimmune conditions
US20230158102A1 (en) 2020-03-02 2023-05-25 Pharma Mar, S.A. Compounds for use in the treatment of coronavirus infection
EP4433462A4 (en) * 2021-11-16 2025-07-16 Prodeg Llc USP9X INHIBITORS
US12168640B2 (en) 2021-11-16 2024-12-17 ProDeg, LLC USP9X inhibitors
WO2024165764A1 (en) 2023-02-10 2024-08-15 Pharma Mar, S.A. Plitidepsin for use in the treatment of non-integrated dna viral infections

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4256108A (en) * 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4782135A (en) * 1980-09-12 1988-11-01 Board Of Trustees, University Of Illinois Composition of matter and process
US5137870A (en) * 1980-09-12 1992-08-11 The Board Of Trustees Of The University Of Illinois Didemnins and nordidemnins
US4493796A (en) * 1980-09-12 1985-01-15 Board Of Trustees, Univ. Of Ill. Didemnins A, B, C, and derivatives thereof, as antiviral agents
DE4120327A1 (de) * 1991-06-20 1992-12-24 Basf Ag Neue peptide, ihre herstellung und verwendung
ES2102322B1 (es) 1995-07-13 1998-03-01 Pharma Mar Sa Procedimiento de preparacion de didemnina a.
US6380156B1 (en) 1996-10-24 2002-04-30 The Board Of Trustees Of The University Of Illnois Total synthesis of the amino hip analogue of didemnin A
DE69735583T2 (de) 1996-10-24 2007-04-05 The Board Of Trustees Of The University Of Illinois, Urbana Semisynthetisches verfahren zur herstellung von didemninanalogen
CA2405779A1 (en) * 2000-04-07 2001-10-18 The Trustees Of The University Of Pennsylvania Tamandarin and didemnin analogs and methods of making and using them
US6509315B1 (en) * 2000-04-07 2003-01-21 The Trustees Of The University Of Pennsylvania Didemnin analogs and fragments and methods of making and using them
UA76718C2 (uk) 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
SE0300461L (sv) * 2003-02-21 2004-04-06 Water Treat Construction I Mot Metod och anordning för att avskilja miljöfarliga ämnen ur en förorenad massa

Also Published As

Publication number Publication date
WO2004084812A2 (en) 2004-10-07
US20070149446A1 (en) 2007-06-28
CN1819837A (zh) 2006-08-16
WO2004084812A3 (en) 2005-10-06
JP2006523214A (ja) 2006-10-12
AU2004224418A1 (en) 2004-10-07
EP1613338A2 (en) 2006-01-11
US8030279B2 (en) 2011-10-04
EP1613338A4 (en) 2009-06-24
CA2519234A1 (en) 2004-10-07

Similar Documents

Publication Publication Date Title
MXPA05010064A (es) Analogos de tamandarin y fragmentos de los mismos y metodos para hacerlos y usarlos.
EP1276491B1 (en) Tamandarin and didemnin analogs and methods of making and using them
US6509315B1 (en) Didemnin analogs and fragments and methods of making and using them
KR100866056B1 (ko) 아플리딘 및 신규의 항종양성 유도체의 합성 방법, 및 그제조 및 이용 방법
CA2852860A1 (en) Cytotoxic peptides and antibody drug conjugates thereof
CA2602070A1 (en) Cyclic nonapeptide amides
US6482921B1 (en) Uridyl peptide antibiotic (UPA) derivatives, their synthesis and use
RU2299887C2 (ru) Способы синтеза аплидина и новых противоопухолевых производных, способы их промышленного получения и применения
AU2006252266A1 (en) Tamandarin and didemnin analogs and methods of making and using them
AU2001267698B2 (en) Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them
AU2001267698A1 (en) Synthetic methods for aplidine and new antitumoral derivatives, methods of making and using them